John Whelan: Why Irish firms face greater challenges doing business in Nigeria
Guinness, an African favourite since the 1960s, has had to weather Nigeria's exchange rate volatility for decades.
Last week GSK, one of the world’s leading pharmaceutical and healthcare companies, employing 1,800 people in its Dungarvan, Cork, Sligo, and Dublin plants, announced plans to stop doing business directly in Nigeria, putting the brakes on its extensive activity in Africa’s largest economy after over half a century of having its own subsidiary there.
Although GSK has not specified a reason for the move, in common with many Irish companies trading there, it has found it increasingly difficult to handle foreign currency payment issues. GSK announced that it will move the distribution of its products to a third-party Nigerian company, which is the route followed by many of its peers.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.
Lunchtime News
Newsletter
Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.
Revoiced
Newsletter
Sign up to the best reads of the week from irishexaminer.com selected just for you.
Most Read
Saturday, March 28, 2026 - 9:00 AM
Saturday, March 28, 2026 - 9:00 AM
Saturday, March 28, 2026 - 10:00 AM






